Therefore, based on our current results, we hypothesise that elevated post-treatment plasma activity of TFPI results in the compensatory release of TFPI associated with up-regulation of the expression of TF both by tumour cells and endothelial cells damaged by adjuvant therapy. Here, TFPI is linked to neoplasm.